CrunchSlaughtered
RPM Ruler
- Messages
- 7,396
You don't know what you are talking about.
-
As a reminder, this section is for civil discussions only. In general, be courteous to others. Debate/discuss/argue the merits of ideas, don't attack people. Personal insults, shill or troll accusations, hate speech, any advocating or wishing death/physical harm, and other rule violations can result in a permanent ban. If you see comments in violation of our rules, please report them.
COVID-19 Coronavirus General Thread
- Thread starter Centurion
- Start date
COVID-19 news, discussion, developments, public health updates, and community conversation.
- Messages
- 11,720
- Name
- Matt
I'm not saying vaccines are bad but, !!Nazi comparisons!!
Anyway, FWIW, unlicensed trusted medications are a lifeline for many people who may not be able to use licensed medications. In the UK the pharmaceutical industry and the government regularly facilitate this knowing that the efficacy and safety of the drug isn't really in question, but economics of licensing it would mean it's otherwise unavailable for people who need it. If you found out your child was severely allergic to their asthma inhaler (for example), you may prefer to shun the licensed product infavour of an unlicensed but safer one, because it would be moronic not to.
I'm not making this up as some kind of moral trick either, our company's largest Pharma customer did/does exactly this. It's overwhelmingly safe, and not something governments have only just done for the vaccine.
- Messages
- 6,158
how do you know? maybe he is an organic local farmer or at least buys from one.
The whole pandemic anecdotal and is not based on evidence but ideology.
Should one point at the moon, you'll look at the finger.
CrunchSlaughtered
RPM Ruler
- Messages
- 7,396
No of the vaccines has a final approval. All of them have only exceptional aprovals. The first product ever allowed for use produced by the company Moderna is exactly the Covid 19 vaccine. Until now they haven't succeded to get the final approval for any of their products. These vaccines are not exrensivly tested on children. They make these tests now on the field and instead of spending billions for these third pfase, they are being paid billions. They are released of any responsibility for any side effects. What if they discover that spending additinally 1 bln Euro would prevent the deaths from side effects of 500 people, would they spend them, when nobody would hold them responsible? I'm not against the vaccines. My wife and I were vaccinated several months ago. But children have no risk from this desease and vaccinating them to prevent the mutation of the virus is a total bullshit.
FDA has approved Pfizer-Biontech for induviduals 16 years or older.
It is available for children from 12-15 under EUA (emergency use authorization)
Pfizer-Biontech Phase 3 clinical trial began late July 2020 with participants aged 12 and over.
Do a simple google search for "covid 19 delta variant children" and "vaccinating to prevent mutation"
Where do you get your "science" from?
CrunchSlaughtered
RPM Ruler
- Messages
- 7,396
From common sense.
CrunchSlaughtered
RPM Ruler
- Messages
- 7,396
It has zero meaning when it has started. The only thing that counts is when it will finish. Putting the vaccines on kids right now is like overtaking in a turn. The road may be slightly used but still there is a chance that a car from the oppisite direction will come. And if the car doen't come, than this does not mean that you were right to undertake the overtaking. Vaccination of healty kids (risk groups not included) only after full approval.
Comparing a vaccine rollout with overtaking has ZERO meaning.
- Messages
- 10,070
Undertaking those overtaking is always dangerous because the gap is very small. It should only be attempted by sports bikes.
CrunchSlaughtered
RPM Ruler
- Messages
- 7,396
The data coming from our ministry of health is not very promissing concerning the protection that the vaccines give. People are vaccinated here predominantly with Pfizer/Biontech and the results for the last 30 days (not including periods in which the Delta variant was not dominant) are as follows: protection against infection - mere 21%, protection against hospitalization - 40%, protection against Covid resulted death - good 75%.
Looks like we will have to live with the virus for quite long.
Looks like we will have to live with the virus for quite long.
- Messages
- 12,235
- Name
- Daniel
You heard right, at least two days you say goodbye to what is called well-being, but hey, it's worth it
D
Deleted member 57437
Guest
Frequently, but hardly always. Both my wife and I experienced nothing more than minimal, very short-term discomfort. A bit of numb pain in the arm where the injection was administered, slight fatigue for a day or two.
- Messages
- 10,070
"The conclusions of the Australian journalist Sharri Markson are close to the latter. She has set up a crime scene around the Wuhan Institute of Virology in central China, with the murder weapon a virus called Sars-CoV-2.
It is a plausible line of research. Just a few miles from the Wuhan food market, where the first major cluster of virus infections was discovered, the institute has arguably the world’s largest collection of the type of bat coronavirus from which Sars-CoV-2 appears to be derived. In the lab at the highest biosecurity level, WIV scientists are doing ‘function gain’ gene editing on bat viruses to increase infectivity for humans.
Could an institute staffer have accidentally become infected with such an amplified virus and carried it outside? In her new book, based on reporting for News Corp newspapers and Sky television, Markson says yes.
It goes even further by playing WIV’s collaborative work with People’s Liberation Army medical researchers to nurture, not completely dismiss the possibility that gain-of-function research isn’t just about investigating potential future pandemics’. to remain’, but to engineer viruses as potential bioweapons."
Other scientists make great use of the presence of a feature called a furin cleavage site on the Sars-CoV-2 spike proteins, which is not seen in other bat viruses, which they say has been used in other cases to create a larger to induce contagiousness. David Baltimore of the California Institute of Technology says this was a “smoking gun to the origin of the virus,” pointing to laboratory origins. Richard Muller of the University of California says it was “like finding a fingerprint at a crime scene.”
Scientists warn of new Covid variant with high number of mutations
The B.1.1.529 variant was first spotted in Botswana and six cases have been found in South Africa
Scientists have said a new Covid variant that carries an “extremely high number” of mutations may drive further waves of disease by evading the body’s defences.
Only 10 cases in three countries have been confirmed by genomic sequencing, but the variant has sparked serious concern among some researchers because a number of the mutations may help the virus evade immunity.
The B.1.1.529 variant has 32 mutations in the spike protein, the part of the virus that most vaccines use to prime the immune system against Covid. Mutations in the spike protein can affect the virus’s ability to infect cells and spread, but also make it harder for immune cells to attack the pathogen.
The variant was first spotted in Botswana, where three cases have now been sequenced. Six more have been confirmed in South Africa, and one in Hong Kong in a traveller returning from South Africa.
Dr Tom Peacock, a virologist at Imperial College London, posted details of the new variant on a genome-sharing website, noting that the “incredibly high amount of spike mutations suggest this could be of real concern”.
In a series of tweets, Peacock said it “very, very much should be monitored due to that horrific spike profile”, but added that it may turn out to be an “odd cluster” that is not very transmissible. “I hope that’s the case,” he wrote.
Dr Meera Chand, the Covid-19 incident director at the UK Health Security Agency, said that in partnership with scientific bodies around the globe, the agency was constantly monitoring the status of Sars-CoV-2 variants as they emerge and develop worldwide.
“As it is in the nature of viruses to mutate often and at random, it is not unusual for small numbers of cases to arise featuring new sets of mutations. Any variants showing evidence of spread are rapidly assessed,” she said.
The first cases of the variant were collected in Botswana on 11 November, and the earliest in South Africa was recorded three days later. The case found in Hong Kong was a 36-year-old man who had a negative PCR test before flying from Hong Kong to South Africa, where he stayed from 22 October to 11 November. He tested negative on his return to Hong Kong, but tested positive on 13 November while in quarantine.
England no longer has a red list to impose restrictions on travellers arriving from abroad. People who are not fully vaccinated must test negative before flying and arrange two PCR tests on arrival. Those who are fully vaccinated need to have a Covid test within two days of landing.
Scientists will be watching the new variant for any sign that it is gaining momentum and spreading more widely. Some virologists in South Africa are already concerned, particularly given the recent rise in cases in Gauteng, an urban area containing Pretoria and Johannesburg, where B.1.1.529 cases have been detected.
Ravi Gupta, a professor of clinical microbiology at Cambridge University, said work in his lab found that two of the mutations on B.1.1.529 increased infectivity and reduced antibody recognition. “It does certainly look a significant concern based on the mutations present,” he said. “However, a key property of the virus that is unknown is its infectiousness, as that is what appears to have primarily driven the Delta variant. Immune escape is only part of the picture of what may happen.”
Prof Francois Balloux, the director of the UCL Genetics Institute, said the large number of mutations in the variant apparently accumulated in a “single burst”, suggesting it may have evolved during a chronic infection in a person with a weakened immune system, possibly an untreated HIV/Aids patient.
“I would definitely expect it to be poorly recognised by neutralising antibodies relative to Alpha or Delta,” he said. “It is difficult to predict how transmissible it may be at this stage. For the time being it should be closely monitored and analysed, but there is no reason to get overly concerned unless it starts going up in frequency in the near future.”
Source: The Guardian
The B.1.1.529 variant was first spotted in Botswana and six cases have been found in South Africa
Scientists have said a new Covid variant that carries an “extremely high number” of mutations may drive further waves of disease by evading the body’s defences.
Only 10 cases in three countries have been confirmed by genomic sequencing, but the variant has sparked serious concern among some researchers because a number of the mutations may help the virus evade immunity.
The B.1.1.529 variant has 32 mutations in the spike protein, the part of the virus that most vaccines use to prime the immune system against Covid. Mutations in the spike protein can affect the virus’s ability to infect cells and spread, but also make it harder for immune cells to attack the pathogen.
The variant was first spotted in Botswana, where three cases have now been sequenced. Six more have been confirmed in South Africa, and one in Hong Kong in a traveller returning from South Africa.
Dr Tom Peacock, a virologist at Imperial College London, posted details of the new variant on a genome-sharing website, noting that the “incredibly high amount of spike mutations suggest this could be of real concern”.
In a series of tweets, Peacock said it “very, very much should be monitored due to that horrific spike profile”, but added that it may turn out to be an “odd cluster” that is not very transmissible. “I hope that’s the case,” he wrote.
Dr Meera Chand, the Covid-19 incident director at the UK Health Security Agency, said that in partnership with scientific bodies around the globe, the agency was constantly monitoring the status of Sars-CoV-2 variants as they emerge and develop worldwide.
“As it is in the nature of viruses to mutate often and at random, it is not unusual for small numbers of cases to arise featuring new sets of mutations. Any variants showing evidence of spread are rapidly assessed,” she said.
The first cases of the variant were collected in Botswana on 11 November, and the earliest in South Africa was recorded three days later. The case found in Hong Kong was a 36-year-old man who had a negative PCR test before flying from Hong Kong to South Africa, where he stayed from 22 October to 11 November. He tested negative on his return to Hong Kong, but tested positive on 13 November while in quarantine.
England no longer has a red list to impose restrictions on travellers arriving from abroad. People who are not fully vaccinated must test negative before flying and arrange two PCR tests on arrival. Those who are fully vaccinated need to have a Covid test within two days of landing.
Scientists will be watching the new variant for any sign that it is gaining momentum and spreading more widely. Some virologists in South Africa are already concerned, particularly given the recent rise in cases in Gauteng, an urban area containing Pretoria and Johannesburg, where B.1.1.529 cases have been detected.
Ravi Gupta, a professor of clinical microbiology at Cambridge University, said work in his lab found that two of the mutations on B.1.1.529 increased infectivity and reduced antibody recognition. “It does certainly look a significant concern based on the mutations present,” he said. “However, a key property of the virus that is unknown is its infectiousness, as that is what appears to have primarily driven the Delta variant. Immune escape is only part of the picture of what may happen.”
Prof Francois Balloux, the director of the UCL Genetics Institute, said the large number of mutations in the variant apparently accumulated in a “single burst”, suggesting it may have evolved during a chronic infection in a person with a weakened immune system, possibly an untreated HIV/Aids patient.
“I would definitely expect it to be poorly recognised by neutralising antibodies relative to Alpha or Delta,” he said. “It is difficult to predict how transmissible it may be at this stage. For the time being it should be closely monitored and analysed, but there is no reason to get overly concerned unless it starts going up in frequency in the near future.”
Source: The Guardian
D
Deleted member 57437
Guest
My wife and I are scheduled for the "booster" (3rd shot) in just less than 2 weeks time. "Wave #4" is threatening to be the most lethal of all so far. Those who have been administered first and second vaccines appear to be relatively safe as do those who have recovered after having contracted the infection (without-or with only mild symptoms should they be infected). However, the virus is reportedly taking a highly alarming toll on those who have not been (and refuse to be) vaccinated, among them many younger people. Especially Bavaria, Sachsen and Thüringen have been hit very hard and there is a critical dearth of beds in their respective clinic intensive care units. A political hot iron is the implementation of mandatory vaccinations for all. The ranks of increasingly militant, radicalized "anti-vaxxers" are large and the constitutional ramifications of mandatory vaccinations demand intense, time-consuming scrutiny.
Similar threads
- Article
- Article
